Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Fresenius Medical price target raised to EUR 67 from EUR 65 at Deutsche Bank » 12:41
07/21/21
07/21
12:41
07/21/21
12:41
FMS

Fresenius Medical

$40.33 /

+0.47 (+1.18%)

Deutsche Bank analyst…

Deutsche Bank analyst Falko Friedrichs raised the firm's price target on Fresenius Medical to EUR 67 from EUR 65 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
FMS Fresenius Medical
$40.33 /

+0.47 (+1.18%)

FMS Fresenius Medical
$40.33 /

+0.47 (+1.18%)

07/20/21 UBS
Fresenius Medical price target raised to EUR 77 from EUR 74 at UBS
05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
Recommendations
Fresenius Medical price target raised to EUR 77 from EUR 74 at UBS » 13:16
07/20/21
07/20
13:16
07/20/21
13:16
FMS

Fresenius Medical

$39.89 /

-0.47 (-1.16%)

UBS analyst Whit Mayo…

UBS analyst Whit Mayo raised the firm's price target on Fresenius Medical to EUR 77 from EUR 74 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
FMS Fresenius Medical
$39.89 /

-0.47 (-1.16%)

FMS Fresenius Medical
$39.89 /

-0.47 (-1.16%)

05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
Over a month ago
Conference/Events
Fresenius Medical management to meet virtually with Oppenheimer » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
FMS

Fresenius Medical

$41.97 /

-0.01 (-0.02%)

Virtual Meeting to be…

Virtual Meeting to be held on June 18 hosted by Oppenheimer.

ShowHide Related Items >><<
FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

Conference/Events
Fresenius Medical management to meet virtually with Oppenheimer » 09:20
06/11/21
06/11
09:20
06/11/21
09:20
FMS

Fresenius Medical

$41.59 /

-0.01 (-0.02%)

Virtual Meeting to be…

Virtual Meeting to be held on June 18 hosted by Oppenheimer.

ShowHide Related Items >><<
FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

Hot Stocks
Humacyte expands global partnership with Fresenius Medical Care » 07:48
06/11/21
06/11
07:48
06/11/21
07:48
FMS

Fresenius Medical

$41.59 /

-0.01 (-0.02%)

, AHAC

Alpha Healthcare Acquisition

$11.14 /

+0.03 (+0.27%)

Humacyte announces the…

Humacyte announces the expansion of the strategic collaboration between Fresenius Medical Care (FMS). Fresenius Medical Care will have the exclusive rights to commercialize Humacyte's 6 millimeter x 42 centimeter human acellular vessel and all improvements thereto, and modifications and derivatives thereof in vascular trauma outside of the United States. Under a Distribution Agreement entered into in June 2018, Fresenius Medical Care obtained the exclusive global rights to commercialize Humacyte's HAVs in the applications of vascular access for hemodialysis and peripheral arterial disease. Under the expanded Distribution Agreement, Fresenius Medical Care and its affiliates will have exclusive rights to develop outside the United States and EU, and to commercialize outside of the United States, Humacyte's HAVs for use in the field of vascular creation, repair, replacement or construction, including renal replacement therapy for dialysis access, the treatment of peripheral arterial disease, and the treatment of vascular trauma. The agreement excludes use of the HAVs by Fresenius Medical Care for coronary artery bypass grafting, pediatric heart surgery, or adhering pancreatic islet cells onto the outer surface of the HAV for use in diabetic patients. Within the United States, Fresenius Medical Care will collaborate with Humacyte in its commercialization of HAVs in the field described above, including adoption of HAVs as a standard of care in patients for which such use is supported by clinical results and health economic analyses. On February 17, 2021, Alpha Healthcare Acquisition (AHAC) and Humacyte announced the execution of a definitive business combination agreement along with a fully committed $175M PIPE financing agreement.

ShowHide Related Items >><<
FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

AHAC Alpha Healthcare Acquisition
$11.14 /

+0.03 (+0.27%)

FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
AHAC Alpha Healthcare Acquisition
$11.14 /

+0.03 (+0.27%)

04/09/21 Lake Street
Lake Street starts Alpha Healthcare Acquisition at Buy ahead of Humacyte closing
04/09/21 Lake Street
Alpha Healthcare Acquisition initiated with a Buy at Lake Street
FMS Fresenius Medical
$41.59 /

-0.01 (-0.02%)

AHAC Alpha Healthcare Acquisition
$11.14 /

+0.03 (+0.27%)

Upgrade
Fresenius Medical upgraded to Buy from Hold at Nord/LB » 05:28
05/12/21
05/12
05:28
05/12/21
05:28
FMS

Fresenius Medical

$39.19 /

-0.21 (-0.53%)

Nord/LB analyst Holger…

Nord/LB analyst Holger Fechner upgraded Fresenius Medical Care to Buy from Hold with a EUR 75 price target.

ShowHide Related Items >><<
FMS Fresenius Medical
$39.19 /

-0.21 (-0.53%)

FMS Fresenius Medical
$39.19 /

-0.21 (-0.53%)

05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
FMS Fresenius Medical
$39.19 /

-0.21 (-0.53%)

Recommendations
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse » 14:14
05/10/21
05/10
14:14
05/10/21
14:14
FMS

Fresenius Medical

$39.59 /

+0.18 (+0.46%)

Credit Suisse analyst…

Credit Suisse analyst Christoph Gretler raised the firm's price target on Fresenius Medical to EUR 68 from EUR 62 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
FMS Fresenius Medical
$39.59 /

+0.18 (+0.46%)

FMS Fresenius Medical
$39.59 /

+0.18 (+0.46%)

04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
FMS Fresenius Medical
$39.59 /

+0.18 (+0.46%)

Over a quarter ago
Recommendations
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays » 13:54
04/28/21
04/28
13:54
04/28/21
13:54
FMS

Fresenius Medical

$39.18 /

-0.19 (-0.48%)

Barclays analyst Hassan…

Barclays analyst Hassan Al-Wakeel lowered the firm's price target on Fresenius Medical to EUR 78 from EUR 85 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
FMS Fresenius Medical
$39.18 /

-0.19 (-0.48%)

FMS Fresenius Medical
$39.18 /

-0.19 (-0.48%)

03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
02/24/21 Truist
Fresenius Medical downgraded to Hold from Buy at Truist
FMS Fresenius Medical
$39.18 /

-0.19 (-0.48%)

Conference/Events
Credit Suisse to hold a virtual conference » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
ABC

AmerisourceBergen

$103.35 /

-0.82 (-0.79%)

, AFMD

Affimed

$5.60 /

-0.07 (-1.23%)

, AMED

Amedisys

$241.61 /

-11.92 (-4.70%)

, AZN

AstraZeneca

$47.17 /

-0.55 (-1.15%)

, BNTX

BioNTech

$97.43 /

-7.43 (-7.09%)

, CSL

Carlisle

$147.55 /

-2.92 (-1.94%)

, CVAC

CureVac

$83.44 /

-9.76 (-10.47%)

, FMS

Fresenius Medical

$34.71 /

-0.615 (-1.74%)

, GLPG

Galapagos

$82.20 /

-2.63 (-3.10%)

, GLTO

Galecto

$9.90 /

-0.45 (-4.35%)

, GSK

GlaxoSmithKline

$34.24 /

+0.15 (+0.44%)

, IVA

Inventiva

$15.00 /

-1.9 (-11.24%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, LNTH

Lantheus

$18.45 /

+0.08 (+0.44%)

, NOV

NOV Inc.

$15.03 /

+0.04 (+0.27%)

, NOVO

Novo Group Inc

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.54 /

-0.635 (-0.72%)

, PHG

Philips

$54.00 /

-1.23 (-2.23%)

, SNY

Sanofi

$45.46 /

-0.495 (-1.08%)

, TAK

Takeda Pharmaceutical

$17.70 /

+0.45 (+2.61%)

, ZEAL

Zealand Pharma

$31.52 /

-1.44 (-4.37%)

2021 London Global…

2021 London Global Healthcare Virtual Conference will be held on March 2-4. Webcast Link

ShowHide Related Items >><<
ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

IVA Inventiva
$15.00 /

-1.9 (-11.24%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

CSL Carlisle
$147.55 /

-2.92 (-1.94%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

AFMD Affimed
$5.60 /

-0.07 (-1.23%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform from In Line at Evercore ISI
AFMD Affimed
$5.60 /

-0.07 (-1.23%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
CSL Carlisle
$147.55 /

-2.92 (-1.94%)

01/26/21 Longbow
Carlisle price target raised to $160 from $150 at Longbow
01/08/21 Oppenheimer
Carlisle price target raised to $175 from $160 at Oppenheimer
11/13/20
Carlisle cut to Hold at Loop Capital on valuation
11/13/20 Loop Capital
Carlisle downgraded to Hold from Buy at Loop Capital
CVAC CureVac
$83.44 /

-9.76 (-10.47%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
02/24/21 Truist
Fresenius Medical downgraded to Hold from Buy at Truist
GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

03/02/21 Barclays
Galapagos price target lowered to EUR 69 from EUR 85.50 at Barclays
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/19/21 Raymond James
Raymond James upgrades 'heavily discounted' Galapagos to Outperform
GLTO Galecto
$9.90 /

-0.45 (-4.35%)

11/23/20 SVB Leerink
SVB Leerink bullish on Galecto, initiates with an Outperform
11/23/20 SVB Leerink
Galecto initiated with an Outperform at SVB Leerink
11/23/20 Credit Suisse
Galecto initiated with an Outperform at Credit Suisse
11/23/20 BofA
Galecto initiated with a Buy at BofA
GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

03/03/21 H.C. Wainwright
Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
02/12/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley
02/11/21 Berenberg
GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg
02/09/21 JPMorgan
GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan
IVA Inventiva
$15.00 /

-1.9 (-11.24%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
IPSEY Ipsen
$0.00 /

+ (+0.00%)

02/16/21 Barclays
Ipsen price target lowered to EUR 89 from EUR 96 at Barclays
01/14/21 Societe Generale
Ipsen upgraded to Buy from Hold at Societe Generale
12/08/20 Morgan Stanley
Ipsen downgraded to Equal Weight from Overweight at Morgan Stanley
12/04/20 BofA
Ipsen downgraded to Neutral from Buy at BofA
LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NOVO Novo Group Inc
$0.00 /

+ (+0.00%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
PHG Philips
$54.00 /

-1.23 (-2.23%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
SNY Sanofi
$45.46 /

-0.495 (-1.08%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
01/29/21 Morgan Stanley
Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
12/29/20 Needham
Needham names Phathom Pharmaceuticals Top Pick for 2021
12/15/20 Needham
Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

CSL Carlisle
$147.55 /

-2.92 (-1.94%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

  • 28
    Jan
  • 13
    Jan
  • 29
    Oct
  • 14
    Aug
  • 23
    Jul
  • 10
    Jul
TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

IVA Inventiva
$15.00 /

-1.9 (-11.24%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

Conference/Events
Credit Suisse to hold a virtual conference » 04:55
03/03/21
03/03
04:55
03/03/21
04:55
ABC

AmerisourceBergen

$104.30 /

+1.22 (+1.18%)

, AFMD

Affimed

$5.67 /

-0.24 (-4.06%)

, AMED

Amedisys

$252.16 /

-2.56 (-1.01%)

, AZN

AstraZeneca

$47.72 /

-0.38 (-0.79%)

, BNTX

BioNTech

$104.98 /

-5 (-4.55%)

, CSL

Carlisle

$150.47 /

+2.445 (+1.65%)

, CVAC

CureVac

$93.20 /

-2.98 (-3.10%)

, FMS

Fresenius Medical

$35.31 /

+0.26 (+0.74%)

, GLPG

Galapagos

$84.42 /

-0.23 (-0.27%)

, GLTO

Galecto

$10.35 /

-0.46 (-4.26%)

, GSK

GlaxoSmithKline

$34.10 /

+0.355 (+1.05%)

, IVA

Inventiva

$16.90 /

+ (+0.00%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, LNTH

Lantheus

$18.32 /

-0.7 (-3.68%)

, NOV

NOV Inc.

$14.99 /

-0.655 (-4.19%)

, NOVO

Novo Group Inc

$0.00 /

+ (+0.00%)

, NVS

Novartis

$88.17 /

+0.73 (+0.83%)

, PHG

Philips

$55.23 /

+0.19 (+0.35%)

, SNY

Sanofi

$45.95 /

+0.07 (+0.15%)

, TAK

Takeda Pharmaceutical

$17.25 /

+0.28 (+1.65%)

, ZEAL

Zealand Pharma

$33.38 /

+0.67 (+2.05%)

2021 London Global…

2021 London Global Healthcare Virtual Conference will be held on March 2-4. Webcast Link

ShowHide Related Items >><<
ZEAL Zealand Pharma
$33.38 /

+0.67 (+2.05%)

TAK Takeda Pharmaceutical
$17.25 /

+0.28 (+1.65%)

SNY Sanofi
$45.95 /

+0.07 (+0.15%)

PHG Philips
$55.23 /

+0.19 (+0.35%)

NVS Novartis
$88.17 /

+0.73 (+0.83%)

NOV NOV Inc.
$14.99 /

-0.655 (-4.19%)

LNTH Lantheus
$18.32 /

-0.7 (-3.68%)

IVA Inventiva
$16.90 /

+ (+0.00%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

GLTO Galecto
$10.35 /

-0.46 (-4.26%)

GLPG Galapagos
$84.42 /

-0.23 (-0.27%)

FMS Fresenius Medical
$35.31 /

+0.26 (+0.74%)

CVAC CureVac
$93.20 /

-2.98 (-3.10%)

CSL Carlisle
$150.47 /

+2.445 (+1.65%)

BNTX BioNTech
$104.98 /

-5 (-4.55%)

AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

AMED Amedisys
$252.16 /

-2.56 (-1.01%)

AFMD Affimed
$5.67 /

-0.24 (-4.06%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform from In Line at Evercore ISI
AFMD Affimed
$5.67 /

-0.24 (-4.06%)

AMED Amedisys
$252.16 /

-2.56 (-1.01%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
BNTX BioNTech
$104.98 /

-5 (-4.55%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
CSL Carlisle
$150.47 /

+2.445 (+1.65%)

01/26/21 Longbow
Carlisle price target raised to $160 from $150 at Longbow
01/08/21 Oppenheimer
Carlisle price target raised to $175 from $160 at Oppenheimer
11/13/20
Carlisle cut to Hold at Loop Capital on valuation
11/13/20 Loop Capital
Carlisle downgraded to Hold from Buy at Loop Capital
CVAC CureVac
$93.20 /

-2.98 (-3.10%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
FMS Fresenius Medical
$35.31 /

+0.26 (+0.74%)

03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
02/24/21 Truist
Fresenius Medical downgraded to Hold from Buy at Truist
GLPG Galapagos
$84.42 /

-0.23 (-0.27%)

03/02/21 Barclays
Galapagos price target lowered to EUR 69 from EUR 85.50 at Barclays
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/19/21 Raymond James
Raymond James upgrades 'heavily discounted' Galapagos to Outperform
GLTO Galecto
$10.35 /

-0.46 (-4.26%)

11/23/20 SVB Leerink
SVB Leerink bullish on Galecto, initiates with an Outperform
11/23/20 SVB Leerink
Galecto initiated with an Outperform at SVB Leerink
11/23/20 Credit Suisse
Galecto initiated with an Outperform at Credit Suisse
11/23/20 BofA
Galecto initiated with a Buy at BofA
GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

02/12/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley
02/11/21 Berenberg
GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg
02/09/21 JPMorgan
GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan
02/08/21 UBS
GlaxoSmithKline price target lowered to 1,320 GBp from 1,450 GBp at UBS
IVA Inventiva
$16.90 /

+ (+0.00%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
IPSEY Ipsen
$0.00 /

+ (+0.00%)

02/16/21 Barclays
Ipsen price target lowered to EUR 89 from EUR 96 at Barclays
01/14/21 Societe Generale
Ipsen upgraded to Buy from Hold at Societe Generale
12/08/20 Morgan Stanley
Ipsen downgraded to Equal Weight from Overweight at Morgan Stanley
12/04/20 BofA
Ipsen downgraded to Neutral from Buy at BofA
LNTH Lantheus
$18.32 /

-0.7 (-3.68%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
NOV NOV Inc.
$14.99 /

-0.655 (-4.19%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NOVO Novo Group Inc
$0.00 /

+ (+0.00%)

NVS Novartis
$88.17 /

+0.73 (+0.83%)

03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
PHG Philips
$55.23 /

+0.19 (+0.35%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
SNY Sanofi
$45.95 /

+0.07 (+0.15%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
TAK Takeda Pharmaceutical
$17.25 /

+0.28 (+1.65%)

01/29/21 Morgan Stanley
Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
12/29/20 Needham
Needham names Phathom Pharmaceuticals Top Pick for 2021
12/15/20 Needham
Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
ZEAL Zealand Pharma
$33.38 /

+0.67 (+2.05%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
ZEAL Zealand Pharma
$33.38 /

+0.67 (+2.05%)

SNY Sanofi
$45.95 /

+0.07 (+0.15%)

PHG Philips
$55.23 /

+0.19 (+0.35%)

NVS Novartis
$88.17 /

+0.73 (+0.83%)

NOV NOV Inc.
$14.99 /

-0.655 (-4.19%)

LNTH Lantheus
$18.32 /

-0.7 (-3.68%)

GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

GLTO Galecto
$10.35 /

-0.46 (-4.26%)

GLPG Galapagos
$84.42 /

-0.23 (-0.27%)

CSL Carlisle
$150.47 /

+2.445 (+1.65%)

AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

AMED Amedisys
$252.16 /

-2.56 (-1.01%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

  • 28
    Jan
  • 13
    Jan
  • 29
    Oct
  • 14
    Aug
  • 23
    Jul
  • 10
    Jul
TAK Takeda Pharmaceutical
$17.25 /

+0.28 (+1.65%)

SNY Sanofi
$45.95 /

+0.07 (+0.15%)

PHG Philips
$55.23 /

+0.19 (+0.35%)

NVS Novartis
$88.17 /

+0.73 (+0.83%)

GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

FMS Fresenius Medical
$35.31 /

+0.26 (+0.74%)

CVAC CureVac
$93.20 /

-2.98 (-3.10%)

BNTX BioNTech
$104.98 /

-5 (-4.55%)

AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

SNY Sanofi
$45.95 /

+0.07 (+0.15%)

PHG Philips
$55.23 /

+0.19 (+0.35%)

NVS Novartis
$88.17 /

+0.73 (+0.83%)

NOV NOV Inc.
$14.99 /

-0.655 (-4.19%)

LNTH Lantheus
$18.32 /

-0.7 (-3.68%)

IVA Inventiva
$16.90 /

+ (+0.00%)

GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

GLTO Galecto
$10.35 /

-0.46 (-4.26%)

GLPG Galapagos
$84.42 /

-0.23 (-0.27%)

CVAC CureVac
$93.20 /

-2.98 (-3.10%)

BNTX BioNTech
$104.98 /

-5 (-4.55%)

AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

AMED Amedisys
$252.16 /

-2.56 (-1.01%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

TAK Takeda Pharmaceutical
$17.25 /

+0.28 (+1.65%)

NOV NOV Inc.
$14.99 /

-0.655 (-4.19%)

GSK GlaxoSmithKline
$34.10 /

+0.355 (+1.05%)

CVAC CureVac
$93.20 /

-2.98 (-3.10%)

BNTX BioNTech
$104.98 /

-5 (-4.55%)

AZN AstraZeneca
$47.72 /

-0.38 (-0.79%)

ABC AmerisourceBergen
$104.30 /

+1.22 (+1.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.